|1|A case-control study on the effect of metabolic gene polymorphisms, nutrition, and their interaction on the risk of non-alcoholic fatty liver disease. (24402518)
Miele L.... Boccia S.
|2|Review of treatment options for nonalcoholic fatty liver disease. (24266914)
Corrado R.L.... Harrison S.A.
|3|Orthotopic liver transplantation in polycystic liver disease]. (23453022)
Arredondo J.... Pardo F.
|4|PNPLA3 I148M polymorphism and progressive liver disease. (24222941)
Dongiovanni P.... Valenti L.
|5|Celiac disease hidden by cryptogenic hypertransaminasemia mistaken for fatty liver. (24020715)
Foroutan M.... Rostami K.
|6|Fibrosis in non-alcoholic fatty liver disease: correlation with simple blood indices and association with tumor necrosis factor-alpha polymorphisms. (23923372)
Chowdhury S.D.... Kurian G.
|7|Hypovitaminosis D is associated with increased whole body fat mass and greater severity of non-alcoholic fatty liver disease. (24118743)
Dasarathy J.... Dasarathy S.
|8|Morphological and metabolic determinants of nonalcoholic fatty liver disease in obese youth: a pilot study. (23497552)
Monteiro P.A.... Freitas I.F.
|9|The relationship between oxidative stress and nonalcoholic fatty liver disease: Its effects on the development of nonalcoholic steatohepatitis. (23743495)
Ucar F.... Akyol O.
|10|Treatment of non-alcoholic fatty liver disease. (24251709)
|11|SERPINB3 expression on B-cell surface in autoimmune diseases and hepatitis C virus-related chronic liver infection. (22829702)
Vidalino L.... Pontisso P.
|12|Metabolic disorders, non-alcoholic fatty liver disease and major liver resection: an underestimated perioperative risk. (23054903)
Zarzavadjian Le Bian A.... Smadja C.
|13|Epicardial adipose tissue relating to anthropometrics, metabolic derangements and fatty liver disease independently contributes to serum high-sensitivity C-reactive protein beyond body fat composition: a study validated with computed tomography. (22014839)
Lai Y.H.... Hung C.L.
|14|Measurement of the coronary flow velocity reserve in patients with non-alcoholic fatty liver disease. (23794311)
PinarbaA9i B.... A9kten A.
|15|IgM-linked SerpinB3 and SerpinB4 in sera of patients with chronic liver disease. (22808225)
Biasiolo A.... Pontisso P.
|16|PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence. (21745286)
Falleti E.... Toniutto P.
|17|Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease. (20392616)
Valenti L.... Fracanzani A.L.
|18|Genetic variants of the bile salt export pump: inducers and modifiers of liver diseases. (21691112)
Kubitz R.... HAoussinger D.
|19|Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease. (21790685)
Petta S.... CraxA- A.
|20|Noncirrhotic human nonalcoholic fatty liver disease induces portal hypertension in relation to the histological degree of steatosis. (21389796)
Francque S.... Michielsen P.
|21|Variant in CD209 promoter is associated with severity of liver disease in chronic hepatitis C virus infection. (20470843)
Ryan E.J.... O'Farrelly C.
|22|What is behind the presence of anti-neutrophil cytoplasmatic antibodies in chronic liver disease? (19453948)
De Riva V.... Angeli P.
|23|Prevalence of non-alcoholic fatty liver disease in children and relationship to metabolic syndrome, insulin resistance, and waist circumference. (19568858)
Tominaga K.... Inaba Y.
|24|Green neutrophilic inclusions in liver disease. (19734487)
Harris V.N.... Smith M.D.
|25|Serum procalcitonin and CRP levels in non-alcoholic fatty liver disease: a case control study. (19222849)
Oruc N.... Batur Y.
|26|The neck-liver axis. Madelung disease as further evidence for an impact of body fat distribution on hepatic histology. (18161705)
Ballestri S.... Loria P.
|27|Accumulation of hedgehog-responsive progenitors parallels alcoholic liver disease severity in mice and humans. (18471524)
Jung Y.... Diehl A.M.
|28|The association between non-alcoholic fatty liver disease and insulin resistance in 20 obese children and adolescents. (17187615)
Ciba I.... Widhalm K.
|29|Expression of PD-1, PD-L1, and PD-L2 in the liver in autoimmune liver diseases. (17311651)
Mataki N.... Miura S.
|30|Demographic and clinicopathological characteristics of nonalcoholic fatty liver disease in the East-Southeastern Anatolia regions in Turkey. (16340230)
Bahcecioglu I.H.... Ozercan I.H.
|31|Polymorphisms of the glutathione S-transferases mu-1 (GSTM1) and theta-1 (GSTT1) and the risk of advanced alcoholic liver disease. (15932176)
Ladero J.M.... AgA_ndez J.A.
|32|HIV infection does not affect the performance of noninvasive markers of fibrosis for the diagnosis of hepatitis C virus-related liver disease. (16284529)
Nunes D.... Horsburgh C.R.
|33|Dihydropyrimidine dehydrogenase and thymidylate synthase activities in hepatocellular carcinomas and in diseased livers. (13680162)
Baba H.... Arii S.
|34|S-Adenosylmethionine, cytokines, and alcoholic liver disease. (12163148)
McClain C.J.... Barve S.
|35|Serum biotinidase activity in children with chronic liver disease and its clinical significance. (11753166)
PabuAscuoA9lu A.... BaA9 M.
|36|The liver in hereditary hemorrhagic telangiectasia (Weber-Rendu-Osler disease). (10636073)
Weik C.... Greiner L.
|37|Screening for cerebral aneurysm in patients with polycystic liver disease. (10624907)
Geevarghese S.K.... Pinson C.W.
|38|Pretransplant management and small bowel-liver transplantation in an infant with microvillus inclusion disease. (9740207)
Randak C.... Vanderhoof J.A.
|39|Hematological abnormalities and cholestatic liver disease in two patients with mevalonate kinase deficiency. (9714005)
Hinson D.D.... Gibson K.M.
|40|Suppression of elevated alanine aminotransferase activity in liver disease by vigabatrin. (9727187)
Williams A.... Coakley J.
|41|Infectious mononucleosis presenting with cholestatic liver disease. (9499346)
Bernstein C.N.... Minuk G.Y.
|42|Prevalence of antibodies to hepatitis C virus and correlation with liver disease in renal transplant patients. (9057953)
Rostaing L.... Durand D.
|43|Genetic polymorphism of cytochrome P4502E1 and risk of alcoholic liver disease in Caucasians. (8747406)
Pirmohamed M.... Park B.K.
|44|Mini-review: tumor necrosis factor (TNF) and TNF soluble receptors (TNF-sR) in liver disease and liver transplantation. (9127637)
Majno P.E.... Mentha G.
|45|Hepatitis B virus markers, hepatitis D virus antigen and hepatitis C virus antibodies in Nigerian patients with chronic liver disease. (8904063)
Ojo O.S.... Fatusi A.O.
|46|Growth factor and procollagen type I gene expression in human liver disease. (7806036)
Malizia G.... McDonald J.A.
|47|A simple method for evaluating prothrombin time in severe liver disease. (8135196)
Dehara K.... Sugata F.
|48|Rescue of mice homozygous for lethal albino deletions: implications for an animal model for the human liver disease tyrosinemia type 1. (8253377)
Kelsey G.... SchA1tz G.
|49|Treatment of chronic liver disease with ursodeoxycholic acid. (2292332)
|50|The cerebral and peripheral uptake of ammonia in liver disease with an hypothesis for the mechanism of hepatic coma. (14367516)
BESSMAN S.P.... Bessman A.N.